Nefopam Reduces Dysesthesia after Percutaneous Endoscopic Lumbar Discectomy
0
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background: Neuropathic pain, including paresthesia/dysesthesia in the lower extremities, always develops and remains for at least one month, to variable degrees, after percutaneous endoscopic lumbar discectomy (PELD). The recently discovered dual analgesic mechanisms of action, similar to those of antidepressants and anticonvulsants, enable nefopam (NFP) to treat neuropathic pain. This study was performed to determine whether NFP might reduce the neuropathic pain component of postoperative pain.Methods: Eighty patients, who underwent PELD due to herniated nucleus pulposus (HNP) at L4-L5, were randomly divided into two equal groups, one receiving NFP (with a mixture of morphine and ketorolac) and the other normal saline (NS) with the same mixture. The number of bolus infusions and the infused volume for 3 days were compared in both groups. The adverse reactions (ADRs) in both groups were recorded and compared. The neuropathic pain symptom inventory (NPSI) score was compared in both groups on postoperative days 1, 3, 7, 30, 60, and 90.Results: The mean attempted number of bolus infusions, and effective infused bolus volume for 3 days was lower in the NFP group for 3 days. The most commonly reported ADRs were nausea, dizziness, and somnolence, in order of frequency in the NFP group. The median NPSI score, and all 5 median sub-scores in the NFP group, were significantly lower than that of the NS group until postoperative day 30. Conclusions: NFP significantly reduced the neuropathic pain component, including paresthesia/dysesthesia until 1 month after PELD. The common ADRs were nausea, dizziness, somnolence, and ataxia. (Korean J Pain 2016; 29: 40-47)
Abstract
Background: Neuropathic pain, including paresthesia/dysesthesia in the lower extremities, always develops and remains for at least one month, to variable degrees, after percutaneous endoscopic lumbar discectomy (PELD). The recently discovered dual analgesic mechanisms of action, similar to those of antidepressants and anticonvulsants, enable nefopam (NFP) to treat neuropathic pain. This study was performed to determine whether NFP might reduce the neuropathic pain component of postoperative pain.Methods: Eighty patients, who underwent PELD due to herniated nucleus pulposus (HNP) at L4-L5, were randomly divided into two equal groups, one receiving NFP (with a mixture of morphine and ketorolac) and the other normal saline (NS) with the same mixture. The number of bolus infusions and the infused volume for 3 days were compared in both groups. The adverse reactions (ADRs) in both groups were recorded and compared. The neuropathic pain symptom inventory (NPSI) score was compared in both groups on postoperative days 1, 3, 7, 30, 60, and 90.Results: The mean attempted number of bolus infusions, and effective infused bolus volume for 3 days was lower in the NFP group for 3 days. The most commonly reported ADRs were nausea, dizziness, and somnolence, in order of frequency in the NFP group. The median NPSI score, and all 5 median sub-scores in the NFP group, were significantly lower than that of the NS group until postoperative day 30. Conclusions: NFP significantly reduced the neuropathic pain component, including paresthesia/dysesthesia until 1 month after PELD. The common ADRs were nausea, dizziness, somnolence, and ataxia. (Korean J Pain 2016; 29: 40-47)
참고문헌 (19)
- 김경훈, "Use of Lidocaine Patch for Percutaneous Endoscopic Lumbar Discectomy", The Korean Journal of Pain, 24(2), pp.74~80 (2011), 대한통증학회
- Cho JY, "Prevention of development of postoperative dysesthesia in transforaminal percutaneous endoscopic lumbar discectomy for intracanalicular lumbar disc herniation : floating retraction technique", Minim Invasive Neurosurg, 54, pp.214~218 (2011)
- Loeser JD, "Bonica's management of pain", pp.1565~1578 (2001), Lippincott Williams & Wilkins
- Gregori-Puigjané E, "Identifying mechanism-of-action targets for drugs and probes", Proc Natl Acad Sci U S A, 109, pp.11178~11183 (2012)
- Moore RA, "Single dose oral analgesics for acute postoperative pain in adults", Cochrane Database Syst Rev, pp.CD008659~ (2011)
- Alfonsi P, "Nefopam, a nonsedative benzoxazocine analgesic, selectively reduces the shivering threshold in unanesthetized subjects", Anesthesiology, 100, pp.37~43 (2004)
- Heel RC, "Nefopam : a review of its pharmacological properties and therapeutic efficacy", Drugs, 19, pp.249~267 (1980)
- Podranski T, "Compartmental pharmacokinetics of nefopam during mild hypothermia", Br J Anaesth, 108, pp.784~791 (2012)
- Bouhassira D, "Development and validation of the Neuropathic Pain Symptom Inventory", Pain, 108, pp.248~257 (2004)
- Czuczwar M, "Nefopam enhances the protective activity of antiepileptics against maximal electroshock-induced convulsions in mice", Pharmacol Rep, 63, pp.690~696 (2011)
- Novelli A, "Nefopam is more potent than carbamazepine for neuroprotection against veratridine in vitro and has anticonvulsant properties against both electrical and chemical stimulation", Amino Acids, 32, pp.323~332 (2007)
- Novelli A, "Nefopam inhibits calcium influx, cGMP formation, and NMDA receptor-dependent neurotoxicity following activation of voltage sensitive calcium channels", Amino Acids, 28, pp.183~191 (2005)
- Verleye M, "Nefopam blocks voltage-sensitive sodium channels and modulates glutamatergic transmission in rodents", Brain Res, 1013, pp.249~255 (2004)
- 김경훈, "Rediscovery of Nefopam for the Treatment of Neuropathic Pain", The Korean Journal of Pain, 27(2), pp.103~111 (2014), 대한통증학회
- Sittl R, "Update on preemptive analgesia : options and limits of preoperative pain therapy", Anaesthesist, 62, pp.789~796 (2013)
- Choi I, "Exiting root injury in transforaminal endoscopic discectomy : preoperative image considerations for safety", Eur Spine J, 22, pp.2481~2487 (2013)
- Durrieu G, "Overview of adverse reactions to nefopam : an analysis of the French Pharmacovigilance database", Fundam Clin Pharmacol, 21, pp.555~558 (2007)
- Haroutiunian S, "The neuropathic component in persistent postsurgical pain : a systematic literature review", Pain, 154, pp.95~102 (2013)
- 주영찬, "Intravenous Nefopam Reduces Postherpetic Neuralgia during the Titration of Oral Medications", The Korean Journal of Pain, 27(1), pp.54~62 (2014), 대한통증학회